
IPBM 2025 highlights emerging precision medicine and clinical advances in pancreatic cancer
Various clinical studies and technological strategies showing promise in applying precision medicine to pancreatic cancer—a disease with a poor prognosis—were highlighted at the International Pancreatobiliary Congress (IPBM 2025) held on Friday in Seoul. …